Literature DB >> 17682495

[Vascular wall lesion and disorder of endothelial vasoregulating function in patients with ankylosing spondylitis].

N A Karoli, A P Rebrov.   

Abstract

Diseases accompanied by endothelial lesion are associated with elevation of mortality. Nowadays, data on endothelial dysfunction in ankylosis spondylitis (AS) are practically absent, while the disease creates "favorable" conditions for endothelial lesion and the development of endothelial dysfunction. The purpose of this work was to evaluate the degree of lesion of the endothelium and vascular wall vasoregulating function in patients with AS. The subjects of the study were 36 AS patients (mean age 36.4 +/- 1.38 years). Exclusion criteria were clinical manifestations of coronary artery disease, arterial hypertension, and other comorbidities during exacerbation period. Signs of vascular wall lesion in a form of an increase in the number of circulating endothelial cells were detected in AS patients. The study revealed disorder of the vasoregulating function of the endothelium in AS patients. Reactive hyperemia test revealed disorder in brachial artery sensitivity to tension in the patients vs. healthy controls. The study demonstrated associations between these disturbances and such factors as system inflammation (fibrinogen), smoking intensity, external respiration disorder, parameters of left ventricular remodeling, and right ventricular diastolic dysfunction.

Entities:  

Mesh:

Year:  2007        PMID: 17682495

Source DB:  PubMed          Journal:  Klin Med (Mosk)        ISSN: 0023-2149


  4 in total

Review 1.  Atherosclerosis and endothelial dysfunction in patients with ankylosing spondylitis.

Authors:  V F Azevedo; R Pecoits-Filho
Journal:  Rheumatol Int       Date:  2010-03-27       Impact factor: 2.631

2.  Endothelial dysfunction in ankylosing spondylitis improves after tumor necrosis factor-alpha blockade.

Authors:  Ashit Syngle; Kanchan Vohra; Anjali Sharma; L Kaur
Journal:  Clin Rheumatol       Date:  2010-03-05       Impact factor: 2.980

Review 3.  Human plasma kallikrein-kinin system: physiological and biochemical parameters.

Authors:  J W Bryant; Z Shariat-Madar
Journal:  Cardiovasc Hematol Agents Med Chem       Date:  2009-07

4.  Upregulation of prolylcarboxypeptidase (PRCP) in lipopolysaccharide (LPS) treated endothelium promotes inflammation.

Authors:  My-Linh Ngo; Fakhri Mahdi; Dhaval Kolte; Zia Shariat-Madar
Journal:  J Inflamm (Lond)       Date:  2009-01-27       Impact factor: 4.981

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.